Compound ID | 1190
TXA-709, active metabolite TXA-707
Class: FtsZ inhibitor
| Spectrum of activity: | Gram-positive |
| Details of activity: | Inhibits the Filamentous Temperature Sensitive mutant Z (FtsZ), a cytoplasmic essential protein in the cell division process. |
| Description: | Synthetic compound; methoxybenzamide; oral administration |
| Institute where first reported: | TAXIS Pharmaceuticals |
| Year first mentioned: | 2015 |
| Highest developmental phase: | Phase 1 |
| Development status: | Active |
| External links: | |
| Guide to Pharmacology: | TXA709 |
| Main Source: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505295/ |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576109/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us.
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.